ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01008852
Recruitment Status : Completed
First Posted : November 6, 2009
Last Update Posted : December 3, 2013
Sponsor:
Collaborator:
Emergent Product Development Seattle LLC
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : July 2013
  Certification/Extension First Submitted : November 12, 2012